Other sector stocks

Other sector definition

The other industries sector groups together companies that can hardly be classified in other sectors.

Other sector is composed of 141 companies with a total market capitalization of $118 bn

Other companies

Ares Capital Corporation (ARCC)

  • Industry: Other
  • Country: USA
  • Market cap: $7.31 bn
  • 3M gains: +48.47 %
  • Avg. Volume: 21.6 M

FIRST REPUBLIC BANK (FRC)

First Republic Bank, together with its subsidiaries, provides private banking, private business banking, real estate lending, and wealth management services to clients in metropolitan areas of the United States.It operates through two segments, Commercial Banking and Wealth Management. The company offers deposit products, such as checking, money market checking, savings, and passbook deposits, as well as certificates of deposit. It also provides a range of lending products that comprise residential mortgage loans, home equity lines of credit, multifamily loans, commercial real estate loans, residential construction loans, personal loans, business loans, and smaller loans and lines of credit to businesses and individuals. The company's loans are secured by single family residences, multifamily buildings, and commercial real estate properties. In addition, it provides wealth management services, which include various investment strategies and products, trust and custody services, full service and online brokerage, financial and estate planning, and access to alternative investments, as well as investing, insurance, and foreign exchange services. As of December 31, 2016, the company offered its services through 74 offices, including 69 preferred banking licensed deposit-taking offices in San Francisco, Palo Alto, Los Angeles, Santa Barbara, Newport Beach, San Diego, Portland, Boston, New York City, Greenwich, and Palm Beach; and 5 offices that provided lending, wealth management, and trust services. First Republic Bank was founded in 1985 and is headquartered in San Francisco, California.

  • Industry: Other
  • Country: USA
  • Market cap: $16.4 bn
  • 3M gains: +39.49 %
  • Avg. Volume: 6.6 M

Zynex, Inc. (ZYXI)

  • Industry: Other
  • Country:
  • Market cap: $159.76 M
  • 3M gains: +150.51 %
  • Avg. Volume: 4.3 M

Prospect Capital Corporation (PSEC)

  • Industry: Other
  • Country: USA
  • Market cap: $2.37 bn
  • 3M gains: -28.98 %
  • Avg. Volume: 20.4 M

ProShares UltraPro QQQ (TQQQ)

The investment seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the NASDAQ-100 Index®.n The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as three times (3x) the daily return of the index. The index, a modified market capitalization-weighted index, includes 100 of the largest non-financial domestic and international issues listed on the NASDAQ Stock Market. The fund is non-diversified.

  • Industry: Other
  • Country: USA
  • Market cap: $3.9 bn
  • 3M gains: +164.85 %
  • Avg. Volume: 253.7 M

Amneal Pharmaceuticals, Inc. (AMRX)

  • Industry: Other
  • Country:
  • Market cap: $3.95 bn
  • 3M gains: +38.66 %
  • Avg. Volume: 10.1 M

Arcturus Therapeutics Ltd. (ARCT)

Arcturus Therapeutics Ltd. operates as an RNA medicines company. Its RNA therapeutics platforms could be applied in various types of RNA medicines, including small interfering RNA, messenger RNA, replicon RNA, antisense RNA, microRNA, and gene editing therapeutics.The company owns LUNAR lipid-mediated delivery and Unlocked Nucleomonomer Agent (UNA) technology, including UNA Oligomers, which are covered by its patent portfolio, including 120 patents and patent applications issued in the United States, Europe, Japan, China, and other countries. Its proprietary UNA technology is used to target individual genes in the human genome, as well as viral genes, and other species for therapeutic purposes. The company develops novel RNA therapeutics through its partnerships with Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, Ultragenyx Pharmaceutical, Inc., Takeda Pharmaceutical Company Limited, Synthetic Genomics Inc., and Cystic Fibrosis Foundation Therapeutics Inc. Arcturus Therapeutics Ltd. has a strategic collaboration with CureVac AG to jointly discover, develop, and commercialize novel messenger RNA therapeutics. The company was founded in 2013 and is headquartered in San Diego, California.

  • Industry: Other
  • Country: USA
  • Market cap: $53.05 M
  • 3M gains: +199.64 %
  • Avg. Volume: 2.1 M

Cboe Global Markets, Inc. (CBOE)

Cboe Global Markets, Inc., through its subsidiaries, operates as an options exchange in the United States. It offers marketplaces for trading options on various market indexes; futures on the VIX Index; options on the stocks of individual corporations comprising equity options; and options on other exchange-traded products that include ETP options, such as exchange-traded funds and exchange-traded notes, as well as other index options.The company owns and operates CBOE primary options market, which offers trading in listed options through a single system that integrates electronic trading and traditional open outcry trading on its trading floor in Chicago; CFE, an all-electronic futures exchange, which provides futures on the VIX Index, as well as on other products; and C2, an all-electronic exchange that offers trading for listed options. Its exchanges operate on its proprietary technology platform, known as CBOE Command. The company has a strategic relationship with S&P OPCO LLC; FTSE Russell; MSCI Inc.; and S&P Dow Jones Indices, LLC. The company was formerly known as CBOE Holdings, Inc. and changed its name to Cboe Global Markets, Inc. in October 2017. Cboe Global Markets, Inc. was founded in 1973 and is headquartered in Chicago, Illinois.

  • Industry: Other
  • Country: USA
  • Market cap: $10.36 bn
  • 3M gains: +26.53 %
  • Avg. Volume: 4.7 M

Golub Capital BDC, Inc. (GBDC)

Golub Capital BDC, Inc. is a business development company and operates as an externally managed closed-end non-diversified management investment company.It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. The company seeks to invest in the United States. It primarily invests in senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

  • Industry: Other
  • Country: USA
  • Market cap: $1.1 bn
  • 3M gains: +10.02 %
  • Avg. Volume: 6.2 M

InflaRx N.V. (IFRX)

InflaRx N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing inhibitors using C5a technology in the United States.Its C5a is an inflammatory mediator involved in the enhancement of a variety of autoimmune and other inflammatory diseases. The company is involved in developing IFX-1, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; ANCA-associated vasculitis, a rare and life-threatening autoimmune disease; and other chronic\u002Fautoimmune diseases, as well as IFX-2 for the treatment of chronic inflammation and autoimmune diseases. It has co-development agreement with Beijing Defengrei Biotechnology Co. Ltd. The company was formerly known as Fireman B.V. and changed its name to InflaRx N.V. in 2017. InflaRx N.V. was founded in 2007 and is headquartered in Jena, Germany.

  • Industry: Other
  • Country: Germany
  • Market cap: $808.18 M
  • 3M gains: +115.04 %
  • Avg. Volume: 6.5 M

Main Street Capital Corporation (MAIN)

Main Street Capital Corporation is a business development company specializing in long- term equity and debt investments in small and lower middle market companies.The firm focuses on investments in, subordinated loans, private equity, venture debt, mezzanine investments, mature, mid venture, industry consolidation, later stage, late venture, emerging growth, management buyouts, change of control transactions, ownership transitions, recapitalizations, strategic acquisitions, refinancing, business expansion capital, growth financings, family estate planning, and other growth initiatives primarily for later stage businesses. It invests in consumer discretionary, consumer staples, energy, healthcare, industrials, information technology, materials, telecommunication services, and utilities sectors. It does not seek to invest in start-up companies or companies with speculative business plans. It seeks to invest in traditional or basic businesses. The firm primarily invests in companies based in the Southern, South Central, and Southwestern regions of the United States but also considers other domestic investment opportunities. It typically invests between $2 million and $75 million in equity and $5 million to $50 million in debt, revenue between $10 million and $150 million, enterprise value between $3 million and $50 million, and EBITDA between $1 million and $20 million. The firm seeks to charge a fixed interest rate between 12 percent and 14 percent, payable in cash, in case of its mezzanine loan investments. The firm typically invests in the form of term debt with equity participation and\u002For direct equity investments. It prefers to maintain fully diluted minority and majority equity positions in its portfolio companies of 5 percent to 50 percent, and may have controlling interests in some instances. The firm also co-invests with other investment firms. It seeks to exit its debt investments through the repayment of the investment from internally generated cash flow and\u002For refinancing within a period of three to seven years. It participates in warrants, PIK (Payment in Kind) interest, convertible securities, junior secured or unsecured, senior secured debt, unitranche debt, equity related, common equity, and preferred equity. Main Street Capital Corporation was founded in 1997 and is based at Houston, Texas.

  • Industry: Other
  • Country: USA
  • Market cap: $2.28 bn
  • 3M gains: -37.94 %
  • Avg. Volume: 4.9 M

New Mountain Finance Corporation (NMFC)

  • Industry: Other
  • Country: USA
  • Market cap: $1.04 bn
  • 3M gains: -42.20 %
  • Avg. Volume: 7.1 M

Apollo Investment Corporation (AINV)

  • Industry: Other
  • Country: USA
  • Market cap: $1.06 bn
  • 3M gains: +38.04 %
  • Avg. Volume: 4.8 M

Center Coast Brookfield MLP & Energy Infrastructur (CEN)

  • Industry: Other
  • Country: USA
  • Market cap: $234.98 M
  • 3M gains: -76.81 %
  • Avg. Volume: 4.8 M

GS Acquisition Holdings Corp. (GSAH)

  • Industry: Other
  • Country:
  • Market cap: $856.46 M
  • 3M gains: -30.25 %
  • Avg. Volume: 11.3 M

Hercules Capital, Inc. (HTGC)

Hercules Capital, Inc., formerly known as Hercules Technology Growth Capital, Inc., is a business development company specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups, to expansion stage including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies.The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and\u002For mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and\u002For expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, seed, startups, early stage, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, energy technology, sustainable and renewable technology, and life sciences. Within technology the firm focuses on advanced specialty materials and chemicals; communication and networking, consumer and business products; consumer products and services, digital media and consumer internet; electronics and computer hardware; enterprise software and services; gaming; healthcare services; information services; business services; media, content and information; mobile; resource management; security software; semiconductors; semiconductors and hardware; and software sector. Within energy technology, it invests in agriculture; clean technology; energy and renewable technology, fuels and power technology; geothermal; smart grid and energy efficiency and monitoring technologies; solar; and wind. Within life sciences, the firm invests in biopharmaceuticals; biotechnology tools; diagnostics; drug discovery, development and delivery; medical devices and equipment; surgical devices; therapeutics; pharma services; and specialty pharmaceuticals. It also invests in educational services. The firm invests primarily in United States based companies and considers investment in the West Coast, Mid-Atlantic regions, Southeast and Midwest; particularly in the areas of software, biotech and information services. It invests generally between $1 million to $40 million in companies with revenues of $10 million to $200 million, generating EBITDA of $2 million to $15 million, focused primarily on business services, communications, electronics, hardware, and healthcare services. The firm invests primarily in private companies but also have investments in public companies. For equity investments, the firm seeks to represent a controlling interest in its portfolio companies which may exceed 25% of the voting securities of such companies. The firm seeks to invest a limited portion of its assets in equipment-based loans to early-stage prospective portfolio companies. These loans are generally for amounts up to $3 million but may be up to $15 million for certain energy technology venture investments. The firm allows certain debt investments have the right to convert a portion of the debt investment into equity. It also co-invests with other private equity firms. The firm seeks to exit its investments through initial public offering, a private sale of equity interest to a third party, a merger or an acquisition of the company or a purchase of the equity position by the company or one of its stockholders. The firm has structured debt with warrants which typically have maturities of between two and seven years with an average of three years; senior debt with an investment horizon of less than three years; equipment loans with an investment horizon ranging from three to four years; and equity related securities with an investment horizon ranging from three to seven years. Hercules Capital, Inc. was founded in December 2003 and is based in Palo Alto, California with additional offices in Hartford, Connecticut; Boston, Massachusetts; Elmhurst, Illinois; Santa Monica, California; McLean, Virginia; New York, New York; Radnor, Pennsylvania; and Washington, District of Columbia.

  • Industry: Other
  • Country: USA
  • Market cap: $1.25 bn
  • 3M gains: +39.79 %
  • Avg. Volume: 7.0 M

Kayne Anderson MLP/Midstream Investment Company (KYN)

Kayne Anderson MLP Investment Company is a closed ended equity mutual fund launched and managed by KA Fund Advisors, LLC.It is co-managed by Kayne Anderson Capital Advisors, L.P. The fund invests in the public equity markets of the United States. It invests in stocks of companies operating in the energy sector. The fund primarily invests in energy-related master limited partnerships. Kayne Anderson MLP Investment Company was formed on June 4, 2004 and is domiciled in the United States.

  • Industry: Other
  • Country: USA
  • Market cap: $2.02 bn
  • 3M gains: +76.20 %
  • Avg. Volume: 8.4 M

Newmark Group, Inc. (NMRK)

Newmark Group, Inc. provides commercial real estate services in the United States. Its investor\u002Fowner services and products include capital markets, which consist of investment sales, debt and structured finance and loan sales, agency leasing, property management, valuation and advisory, and loan servicing; and diligence and underwriting and government sponsored entity lending.The company's occupier services and products comprise tenant representation, real estate management technology systems, workplace and occupancy strategy, global corporate services consulting, project management, lease administration, and facilities management. It serves occupiers\u002Freal estate tenants, owners\u002Flandlords, and developers of real estate in the United States; and corporations and institutional investors internationally. The company was founded in 1929 and is headquartered in New York, New York. Newmark Group, Inc. is a subsidiary of BGC Partners, Inc.

  • Industry: Other
  • Country:
  • Market cap: $1.83 bn
  • 3M gains: +25.65 %
  • Avg. Volume: 9.8 M

Oxford Lane Capital Corp. (OXLC)

Oxford Lane Capital Corp. is a close ended fund launched and managed by Oxford Lane Management LLC. It invests in fixed income securities.The fund primarily invests in securitization vehicles which in turn invest in senior secured loans made to companies whose debt is rated below investment grade or is unrated. Oxford Lane Capital Corp was formed on June 9, 2010 and is domiciled in the United States.

  • Industry: Other
  • Country: USA
  • Market cap: $367.2 M
  • 3M gains: +21.45 %
  • Avg. Volume: 9.8 M

Invesco Optimum Yield Diversified Commodity Strategy No K-1 ET (PDBC)

The investment seeks long term capital appreciation.\n The fund is an actively managed exchange-traded fund (\"ETF\") that seeks to achieve its investment objective by investing in a combination of financial instruments that are economically linked to the world's most heavily traded commodities.Commodities are assets that have tangible properties, such as oil, agricultural produce or raw metals. It is non-diversified.

  • Industry: Other
  • Country: USA
  • Market cap: $1.86 bn
  • 3M gains: -24.07 %
  • Avg. Volume: 16.4 M

Other sector industries

Industry
Other

Novartis stock

The featured stock this month is Novartis, a leading pharma company that markets a range of healthcare products worldwide. Novartis stock made all-time highs last July, and since then the share has been sliding progressively and it's now down close to 10% from ATH.

Top performing stocks in the Other sector

Company3M gain6M gain
Ares Capital+48.47 %-14.91 %
FRC+39.49 %-5.00 %
Zynex+150.51 %+221.10 %
Prospect Capital-28.98 %-26.28 %